GNAO1

Clinical trials for GNAO1 explained in plain language.

Never miss a new study

Get alerted when new GNAO1 trials appear

Sign up with your email to follow new studies for GNAO1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Zinc shows promise for rare neurological condition

Symptom relief Completed

This study tested whether taking zinc by mouth every day is safe and doable for people with GNAO1-related disorders, a rare genetic condition causing movement problems, seizures, and developmental delays. Thirteen participants aged 6 months to 30 years took zinc for 6 months. Res…

Matched conditions: GNAO1

Phase: PHASE2 • Sponsor: Children's University Hospital Cologne, Germany • Aim: Symptom relief

Last updated May 12, 2026 13:42 UTC

GNAO1

Get alerted when new GNAO1 trials appear

Zinc shows promise for rare neurological condition